Care
Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.
Employees will have access to clinical content and more than 900 U.S. clinics that specialize in fertility, urology and menopause.
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Selected early versions will be slated for real-world deployment.
HIMSS25
Joan Webley of Hospitals Without Borders, which provides modular hospitals and clinics to regions in need, says attending HIMSS25 helped her gain insights and connect with people interested in the organization's mission.
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Patients will get same-day delivery and access to treatments like GLP-1s and hormone therapies.
Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.